PSEN1 and Alzheimer disease: In 2013, Cohen et al. introduced the TgF344-AD rat model, characterized by the co-expression of two human gene mutations implicated in AD: hAPP with the Swedish mutation and human PSEN-1 (hPSEN-1) with Δ exon 9 mutations under the control of the murine PrP promoter [20].